Evidence map›Paper›PMID 24394191›Full record

ReviewNature reviews. Nephrology2014

Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Jochen Reiser, Sanja Sever, Christian Faul

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Vascular Toxicities of Cancer Therapies: 2025 Update.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  2. Article
  3. Insulin-activated store-operated CaNature communications · 2021
    Article
  4. Role of actin cytoskeleton in podocytes.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  5. Article
  6. Review
  7. Human aging and disease: Lessons from age-related macular degeneration.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Prospects for Precision Medicine in Glomerulonephritis Treatment.Canadian journal of kidney health and disease · 2018
    Review
  9. Klotho May Ameliorate Proteinuria by Targeting TRPC6 Channels in Podocytes.Journal of the American Society of Nephrology : JASN · 2017
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Ret is critical for podocyte survival following glomerular injury in vivo.American journal of physiology. Renal physiology · 2015
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Jochen ReiserDepartment of Medicine, Rush University Medical Center, 1735 West Harrison Street, Cohn Building, Suite 724, Chicago, IL 60612, USA.
Sanja SeverDepartment of Medicine, Division of Nephrology, Massachusetts General Hospital and Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA.
Christian FaulDivision of Nephrology and Hypertension, University of Miami Miller School of Medicine, 1580 North West 10th Avenue (R-762), Batchelor Building 626, Miami, FL 33136, USA.
Massachusetts General Hospital · USRush University Medical Center · USUniversity of Miami · US

Funding

Use of small molecules that stabilize dynamin rings in podocytopathiesR01DK087985 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI SEVER, SANJA · 2011 to 2020
$3.4M
Role of dynamin for podocytes structure and functionR01DK093773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI SEVER, SANJA · 2011 to 2021
$3.4M
Role of Circulating suPAR in FSGSR01DK101350 · NIDDK · RUSH UNIVERSITY MEDICAL CENTER · PI REISER, JOCHEN · 2013 to 2017
$2.6M
Proteolytic Regulation of Podocyte Function by Cathepsin L.R01DK073495 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI REISER, JOCHEN · 2006 to 2015
$2.4M
Glomerular Disease Mechanisms mediated by Podocyte TRPC6R01DK089394 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI REISER, JOCHEN · 2010 to 2014
$1.6M
NIDDK NIH HHS DK073495NIDDK NIH HHS DK087985NIDDK NIH HHS DK089394NIDDK NIH HHS DK093773NIDDK NIH HHS DK101350NIDDK NIH HHS R01 DK073495NIDDK NIH HHS R01 DK087985NIDDK NIH HHS R01 DK089394NIDDK NIH HHS R01 DK093773NIDDK NIH HHS R01 DK101350
6 · The paper itself

Abstract

The mammalian kidney filtration barrier is a complex multicellular, multicomponent structure that maintains homeostasis by regulating electrolytes, acid-base balance, and blood pressure (via maintenance of salt and water balance). To perform these multiple functions, podocytes--an important component of the filtration apparatus--must process a series of intercellular signals. Integrating these signals with diverse cellular responses enables a coordinated response to various conditions. Although mature podocytes are terminally differentiated and cannot proliferate, they are able to respond to growth factors. It is possible that the initial response of podocytes to growth factors is beneficial and protective, and might include the induction of hypertrophic cell growth. However, extended and/or uncontrolled growth factor signalling might be maladaptive and could result in the induction of apoptosis and podocyte loss. Growth factors signal via the activation of receptor tyrosine kinases (RTKs) on their target cells and around a quarter of the 58 RTK family members that are encoded in the human genome have been identified in podocytes. Pharmacological inhibitors of many RTKs exist and are currently used in experimental and clinical cancer therapy. The identification of pathological RTK-mediated signal transduction pathways in podocytes could provide a starting point for the development of novel therapies for glomerular disorders.

Indexed as

AnimalsApoptosisCell ProliferationHomeostasisHumansKidney DiseasesPodocytesReceptor Protein-Tyrosine KinasesSignal TransductionReceptor Protein-Tyrosine Kinases

Identifiers

PMID24394191
PMCPMC4109315
OpenAlexW2016963171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.